Anika Therapeutics Inc
NASDAQ:ANIK

Watchlist Manager
Anika Therapeutics Inc Logo
Anika Therapeutics Inc
NASDAQ:ANIK
Watchlist
Price: 17.04 USD 0.95% Market Closed
Market Cap: 252.2m USD
Have any thoughts about
Anika Therapeutics Inc?
Write Note

Wall Street
Price Targets

ANIK Price Targets Summary
Anika Therapeutics Inc

Wall Street analysts forecast ANIK stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ANIK is 35.19 USD with a low forecast of 32.32 USD and a high forecast of 38.85 USD.

Lowest
Price Target
32.32 USD
90% Upside
Average
Price Target
35.19 USD
107% Upside
Highest
Price Target
38.85 USD
128% Upside
Anika Therapeutics Inc Competitors:
Price Targets
IGMS
IGM Biosciences Inc
77% Upside
300122
Chongqing Zhifei Biological Products Co Ltd
16% Upside
4599
StemRIM Inc
101% Upside
IMTX
Immatics NV
125% Upside
145020
Hugel Inc
20% Upside
397030
AprilBio Co Ltd
59% Upside
MOLN
Molecular Partners AG
77% Upside
1672
Ascletis Pharma Inc
32% Upside

Revenue
Forecast

Revenue Estimate
Anika Therapeutics Inc

For the last 8 years the compound annual growth rate for Anika Therapeutics Inc's revenue is 8%. The projected CAGR for the next 3 years is -9%.

8%
Past Growth
-9%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Anika Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Anika Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ANIK's stock price target?
Price Target
35.19 USD

According to Wall Street analysts, the average 1-year price target for ANIK is 35.19 USD with a low forecast of 32.32 USD and a high forecast of 38.85 USD.

What is Anika Therapeutics Inc's Revenue forecast?
Projected CAGR
-9%

For the last 8 years the compound annual growth rate for Anika Therapeutics Inc's revenue is 8%. The projected CAGR for the next 3 years is -9%.

Back to Top